OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
The authors describe considerations and best practices for meeting drug substance uniformity.
The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.